Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/2634
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BUNTINX, Mieke | - |
dc.contributor.author | STINISSEN, Piet | - |
dc.contributor.author | STEELS, Paul | - |
dc.contributor.author | AMELOOT, Marcel | - |
dc.contributor.author | RAUS, Jef | - |
dc.date.accessioned | 2007-11-15T14:55:13Z | - |
dc.date.available | 2007-11-15T14:55:13Z | - |
dc.date.issued | 2002 | - |
dc.identifier.citation | CRITICAL REVIEWS IN IMMUNOLOGY, 22(5-6). p. 391-424 | - |
dc.identifier.issn | 1040-8401 | - |
dc.identifier.uri | http://hdl.handle.net/1942/2634 | - |
dc.description.abstract | In this review, new insights into the immunopathogenesis of multiple sclerosis (MS) are discussed, with special focus on the potential mechanisms leading to neuroinflammation in MS-that is, the role of autoreactive T cells, infections, and neurodegenerative events. Oligodendrocytes are considered to be the target of autoimmune inflammation in the CNS of MS patients. Some important features of oligodendrocyte biology are discussed, together with the molecular mechanisms that are potentially involved in oligodendrocyte injury. These include injury mechanisms that might be executed by the adaptive and innate immune system, via cytokines and/or oligodendrocyte receptors, or as a consequence of nitrative and oxidative stress, and excitotoxicity. The mode of cell death of oligodendrocytes in MS is discussed, in addition to the mechanisms of axonal injury as observed in pathology- and imaging-based studies. Finally, recent progress in therapeutic strategies that may interfere with these pathological processes are reviewed, with a focus on repair strategies, such as gene therapy, antibody-mediated remyelination, and stem cell therapy. | - |
dc.language.iso | en | - |
dc.publisher | BEGELL HOUSE INC | - |
dc.subject.other | T lymphocyte; autoimmunity; myelin; remyelination; axonal injury | - |
dc.title | Immune-mediated oligodendrocyte injury in multiple sclerosis: Molecular mechanisms and therapeutic interventions | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 424 | - |
dc.identifier.issue | 5-6 | - |
dc.identifier.spage | 391 | - |
dc.identifier.volume | 22 | - |
local.format.pages | 34 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Limburgs Univ Ctr, Biomed Onderzoeksinst, B-3590 Diepenbeek, Belgium. Transnatl Univ Limburg, Sch Life Sci, B-3590 Diepenbeek, Belgium.Stinissen, P, Limburgs Univ Ctr, Biomed Onderzoeksinst, Univ Campus A, B-3590 Diepenbeek, Belgium. | - |
local.type.refereed | Refereed | - |
local.type.specified | Review | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.isi | 000182776300003 | - |
dc.identifier.url | http://www.begellhouse.com/journals/2ff21abf44b19838,0607a66912300b08,7ed1093571d161fa.html | - |
item.validation | ecoom 2004 | - |
item.accessRights | Closed Access | - |
item.fullcitation | BUNTINX, Mieke; STINISSEN, Piet; STEELS, Paul; AMELOOT, Marcel & RAUS, Jef (2002) Immune-mediated oligodendrocyte injury in multiple sclerosis: Molecular mechanisms and therapeutic interventions. In: CRITICAL REVIEWS IN IMMUNOLOGY, 22(5-6). p. 391-424. | - |
item.fulltext | No Fulltext | - |
item.contributor | BUNTINX, Mieke | - |
item.contributor | STINISSEN, Piet | - |
item.contributor | STEELS, Paul | - |
item.contributor | AMELOOT, Marcel | - |
item.contributor | RAUS, Jef | - |
crisitem.journal.issn | 1040-8401 | - |
crisitem.journal.eissn | 2162-6472 | - |
Appears in Collections: | Research publications |
WEB OF SCIENCETM
Citations
35
checked on May 10, 2024
Page view(s)
70
checked on Jun 19, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.